Follow the Attovia Therapeutics, Inc. share price and the full insider trade history of the company, a listed equity based in United States. Shares trade on US US, under the authority of SEC (Form 4). Market capitalisation: €2.2bn. The latest transaction was reported on 10 August 2026 (C). Among the most active insiders: Frazier Life Sciences XI, L.P.. The full history is openly available.
15
Insider Decl.
n/a
Thresholds
€28m
5 ops.
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Attovia Therapeutics, Inc. Strong Buy (bullish), based on 12 analysts. Average price target: US$59.30.
48Σ signal
Buys €28mn/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.